2D-LC–MS/MS to Measure Cleaved High-Molecular-Weight Kininogen in Human Plasma as A Biomarker for C1-Inh-Hae

References

• Zuraw BL , ChristiansenSC. HAE pathophysiology and underlying mechanisms. Clin. Rev. Allergy Immunol. 51 (2), 216–229 (2016).
   PubMed Web of Science ®Google Scholar
• Zeerleder S . C1-inhibitor: more than a serine protease inhibitor. Semin. Thromb. Hemost. 37 (4), 362–374 (2011).
   PubMed Web of Science ®Google Scholar
• Davis AE, 3rd, LuF, MejiaP. C1 inhibitor, a multi-functional serine protease inhibitor. Thromb. Haemost. 104 (5), 886–893 (2010).
   PubMed Web of Science ®Google Scholar
• Cicardi M , BerettaA, ColomboM, GioffreD, CugnoM, AgostoniA. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema. Clin. Exp. Immunol. 106 (3), 475–480 (1996).
   PubMed Web of Science ®Google Scholar
• Kaplan AP , GreavesMW. Angioedema. J. Am. Acad. Dermatol. 53 (3), 373–388 ; quiz 389–392 (2005).
   PubMed Web of Science ®Google Scholar
• Nussberger J , CugnoM, AmstutzC, CicardiM, PellacaniA, AgostoniA. Plasma bradykinin in angio-oedema. Lancet351 (9117), 1693–1697 (1998).
   PubMed Web of Science ®Google Scholar
• Agostoni A , CicardiM. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore)71 (4), 206–215 (1992).
   PubMed Web of Science ®Google Scholar
• Colman RW , SchmaierAH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood90 (10), 3819–3843 (1997).
   PubMed Web of Science ®Google Scholar
• Berrettini M , LammleB, WhiteTet al. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood68 (2), 455–462 (1986).
   PubMed Web of Science ®Google Scholar
• Cugno M , CicardiM, BottassoBet al. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood89 (9), 3213–3218 (1997).
   PubMed Web of Science ®Google Scholar
• Mori K , NagasawaS. Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein. J. Biochem. 89 (5), 1465–1473 (1981).
   PubMed Web of Science ®Google Scholar
• Baroso R , SellierP, DefendiFet al. Kininogen cleavage assay: diagnostic assistance for kinin-mediated angioedema conditions. PLoS ONE11 (9), e0163958 (2016).
   PubMed Web of Science ®Google Scholar
• Couture R , BlaesN, GirolamiJP. Kinin receptors in vascular biology and pathology. Curr. Vasc. Pharmacol. 12 (2), 223–248 (2014).
   PubMed Web of Science ®Google Scholar
• Gainer JV , MorrowJD, LovelandA, KingDJ, BrownNJ. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N. Engl. J. Med. 339 (18), 1285–1292 (1998).
   PubMed Web of Science ®Google Scholar
• Leeb-Lundberg LM , MarceauF, Muller-EsterlW, PettiboneDJ, ZurawBL. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57 (1), 27–77 (2005).
   PubMed Web of Science ®Google Scholar
• Longhurst H , CicardiM. Hereditary angio-oedema. Lancet379 (9814), 474–481 (2012).
   PubMed Web of Science ®Google Scholar
• Schmaier AH . Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system. Int. Immunopharmacol. 8 (2), 161–165 (2008).
   PubMed Web of Science ®Google Scholar
• Banerji A , BusseP, ShennakMet al. Inhibiting plasma kallikrein for hereditary angioedema prophylaxis. N. Engl. J. Med. 376 (8), 717–728 (2017).
   PubMed Web of Science ®Google Scholar
• Chyung Y , VinceB, IarrobinoRet al. A Phase 1 study investigating DX-2930 in healthy subjects. Ann. Allergy. Asthma. Immunol. 113 (4), 460–466 ; e462 (2014).
   PubMed Web of Science ®Google Scholar
• Kenniston JA , FaucetteRR, MartikDet al. Inhibition of plasma kallikrein by a highly specific active site blocking antibody. J. Biol. Chem. 289 (34), 23596–23608 (2014).
   PubMed Web of Science ®Google Scholar
• Cugno M , ZanichelliA, BellatorreAG, GriffiniS, CicardiM. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency. Allergy64 (2), 254–257 (2009).
   PubMed Web of Science ®Google Scholar
• Schapira M , SilverLD, ScottCFet al. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N. Engl. J. Med. 308 (18), 1050–1053 (1983).
   PubMed Web of Science ®Google Scholar
• Kaufman N , PageJD, PixleyRA, ScheinR, SchmaierAH, ColmanRW. Alpha 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. Blood77 (12), 2660–2667 (1991).
   PubMed Web of Science ®Google Scholar
• Suffritti C , ZanichelliA, MaggioniL, BonanniE, CugnoM, CicardiM. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency. Clin. Exp. Allergy44 (12), 1503–1514 (2014).
   PubMed Web of Science ®Google Scholar
• Cugno M , CicardiM, CoppolaR, AgostoniA. Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies. Immunopharmacology33 (1–3), 361–364 (1996).
   PubMedGoogle Scholar
• An B , ZhangM, QuJ. Toward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry. Drug Metab. Dispos. 42 (11), 1858–1866 (2014).
   PubMedGoogle Scholar
• Becker JO , HoofnagleAN. Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC–MS/MS. Bioanalysis4 (3), 281–290 (2012).
   PubMed Web of Science ®Google Scholar
• Heudi O , BarteauS, ZimmerDet al. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC–MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. Anal. Chem. 80 (11), 4200–4207 (2008).
   PubMed Web of Science ®Google Scholar
• Neubert H , FanYY, Fernandez OcanaM. Quantification of protein biomarkers in tissues: new capabilities with pellet digestion peptide immunoaffinity LC–MS/MS. Bioanalysis8 (15), 1551–1555 (2016).
   PubMed Web of Science ®Google Scholar
• Neubert H , GaleJ, MuirheadD. Online high-flow peptide immunoaffinity enrichment and nanoflow LC–MS/MS: assay development for total salivary pepsin/pepsinogen. Clin. Chem. 56 (9), 1413–1423 (2010).
   PubMed Web of Science ®Google Scholar
• Palandra J , FinelliA, ZhuM, MasferrerJ, NeubertH. Highly specific and sensitive measurements of human and monkey interleukin 21 using sequential protein and tryptic peptide immunoaffinity LC–MS/MS. Anal. Chem. 85 (11), 5522–5529 (2013).
   PubMed Web of Science ®Google Scholar
• Qu M , AnB, ShenSet al. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry. Mass Spectrom. Rev. 36 (6), 734–754 (2016).
   PubMed Web of Science ®Google Scholar
• Sano S , TagamiS, HashimotoYet al. Absolute quantitation of low abundance plasma APL1beta peptides at sub-fmol/ml Level by SRM/MRM without immunoaffinity enrichment. J. Proteome Res. 13 (2), 1012–1020 (2014).
   PubMed Web of Science ®Google Scholar
• Ackermann BL , BernaMJ. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers. Expert Rev. Proteomics4 (2), 175–186 (2007).
   PubMed Web of Science ®Google Scholar
• Berna MJ , ZhenY, WatsonDE, HaleJE, AckermannBL. Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal. Chem. 79 (11), 4199–4205 (2007).
   PubMed Web of Science ®Google Scholar
• Patel BB , BarreroCA, BravermanAet al. Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics. J. Proteome Res. 11 (12), 5947–5958 (2012).
   PubMed Web of Science ®Google Scholar
• Shen Y , ZhangG, YangJet al. Online 2D-LC–MS/MS assay to quantify therapeutic protein in human serum in the presence of pre-existing antidrug antibodies. Anal. Chem. 87 (16), 8555–8563 (2015).
   PubMed Web of Science ®Google Scholar
• US FDA. Guidance for Industry: Bioanalytical Method Validation (2001,). www.Fda.Gov/Downloads/Drugs/Guidance/Ucm070107.Pdf.
   Google Scholar
• Jenkins R , DugganJX, AubryAFet al. Recommendations for validation of LC–MS/MS bioanalytical methods for protein biotherapeutics. AAPS J. 17 (1), 1–16 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang JC , ClaffeyK, SakthivelRet al. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. 14 (15), 2589–2600 (2000).
   PubMed Web of Science ®Google Scholar
• Fung EN , BryanP, KozhichA. Techniques for quantitative LC–MS/MS analysis of protein therapeutics: advances in enzyme digestion and immunocapture. Bioanalysis8 (8), 847–856 (2016).
   PubMed Web of Science ®Google Scholar
• Furlong MT , TitschC, XuW, JiangH, JemalM, ZengJ. An exploratory universal LC–MS/MS assay for bioanalysis of hinge region-stabilized human IgG4 mAbs in clinical studies. Bioanalysis6 (13), 1747–1758 (2014).
   PubMed Web of Science ®Google Scholar
• Gong C , ZhengN, ZengJ, AubryAF, ArnoldME. Post-pellet-digestion precipitation and solid phase extraction: a practical and efficient workflow to extract surrogate peptides for ultra-high performance liquid chromatography--tandem mass spectrometry bioanalysis of a therapeutic antibody in the low ng/ml range. J. Chromatogr. A1424, 27–36 (2015).
   PubMed Web of Science ®Google Scholar
• Jiang H , ZengJ, TitschCet al. Fully validated LC–MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum. Anal. Chem. 85 (20), 9859–9867 (2013).
   PubMed Web of Science ®Google Scholar
• Yuan L , ArnoldME, AubryAF, JiQC. Simple and efficient digestion of a monoclonal antibody in serum using pellet digestion: comparison with traditional digestion methods in LC–MS/MS bioanalysis. Bioanalysis4 (24), 2887–2896 (2012).
   PubMed Web of Science ®Google Scholar
• Sandra K , MortierK, JorgeLet al. LC–MS/MS quantification of next-generation biotherapeutics: a case study for an IgE binding Nanobody in cynomolgus monkey plasma. Bioanalysis6 (9), 1201–1213 (2014).
   PubMed Web of Science ®Google Scholar
• Zhang G , ZhangY, FastDM, LinZ, SteenwykR. Ultra sensitive quantitation of endogenous oxytocin in rat and human plasma using a two-dimensional liquid chromatography-tandem mass spectrometry assay. Anal. Biochem. 416 (1), 45–52 (2011).
   PubMed Web of Science ®Google Scholar
• Lee JW , DevanarayanV, BarrettYCet al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23 (2), 312–328 (2006).
   PubMed Web of Science ®Google Scholar
• Pellacani A , BrunnerHR, NussbergerJ. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin. Sci. (Lond.)87 (5), 567–574 (1994).
   PubMed Web of Science ®Google Scholar